title: [PROLONGED RETAINED PLACENTA ACCRETA IN THE UTERUS AFTER VAGINAL DELIVERY (A CASE REPORT AND REVIEW OF LITERATURE)].
abstract: A case of prolonged retention in the uterus of placenta accreta after vaginal delivery is reported in the paper. The patient was 20 years old G3, P0 with two pregnancy terminations on request. She was admitted to the obstetric department of a regional hospital one day after the EDD with irregular contractions and non reassuring CTG. A few hours later intrauterine fetal demise occurred. Spontaneous labor commenced and a stillborn growth retarded fetus was delivered. Methergin was administered during the third stage of labor, but the placenta was not separated even after repeated Crede maneuvers, the last one under anesthesia. Since cervical spasm was present, the attempts for manual or instrumental separation of the placenta were unsuccessful. There was no genital bleeding, so further conservative approach was followed including continuous IV infusion of uterotonics, combined antibiotic therapy, close observation of the vital signs and the laboratory indicators. Three days after delivery the patient was transferred to a University Hospital because of subfebrile temperature. Her general condition on admission, although subfebrile, was good, there was no genital bleeding, the cervix was closed. The subfebrile temperatrure persisted despite antibiotic treatment; CRP was elevated (51,9 mg/l.). Because of suspicion for endomyometritis, on day 8th after delivery instrumental extraction of the placenta was undertaken with preparedness for hysterectomy in case of need. Although the procedure was difficult, with the placenta being extracted in parts, bleeding was scarce. The post operative period was uneventful and the patient was discharged from hospital five days after the intervention. A review of literature on the obstetric management of cases with retained placenta accreta after vaginal delivery is presented. The existing therapeutic options are discussed including their advantages and complications.
authors.forename: S V
authors.initials: SV
authors.lastname: Nashar
authors.forename: V
authors.initials: V
authors.lastname: Dimitrova
authors.forename: V
authors.initials: V
authors.lastname: Zlatkov
authors.forename: B
authors.initials: B
authors.lastname: Frandeva
authors.forename: A
authors.initials: A
authors.lastname: Dimitrov
mesh_terms: D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D036861:Delivery, Obstetric / Q000009:adverse effects*; D005260:Female; D006801:Humans; D010920:Placenta / Q000473:pathology / Q000601:surgery; D010921:Placenta Accreta / Q000175:diagnosis* / Q000473:pathology / Q000601:surgery / Q000628:therapy*; D018457:Placenta, Retained / Q000175:diagnosis* / Q000473:pathology / Q000601:surgery / Q000628:therapy*; D011247:Pregnancy; D050497:Stillbirth / Q000453:epidemiology; D055815:Young Adult
chemical_list: D000900:Anti-Bacterial Agents